[[abstract]]Background: To analyze the trifecta outcome (continence, potency, and cancer control) in 300 cases of robotic-assisted laparoscopic radical prostatectomy (RARP). Methods: A prospective assessment of outcomes in 300 consecutive patients that underwent a RARP performed by a single surgeon. Patients were grouped according to D'Amico risk criteria: Group I consisted of 'low-risk' cases (n = 64), Group II consisted of 'intermediate-risk' cases (n = 88), and Group III consisted of 'high-risk' cases (n = 148). Patients were evaluated for perioperative complications and the trifecta outcome. Results: The operation time, blood loss, post-operative stay, duration of urethral catheterization, and perioperative complication rate were simila...
Objective: We report our initial experience with 62 patients undergoing robotic-assisted laparoscopi...
OBJECTIVE • To evaluate early trifecta outcomes after robotic-assisted radical prostatectomy (RARP) ...
To analyze the learning curve for cancer control from an initial 250 cases (Group I) and subsequent ...
OBJECTIVE: To evaluate the trifecta outcome and its preoperative predictors in a series of consecuti...
Introduction: In this retrospective study, we report outcomes of robot-assisted laparoscopic radical...
Historically, the ideal outcome of radical prostatectomy (RP) has been measured by achievement of th...
Historically, the ideal outcome of radical prostatectomy (RP) has been measured by achievement of th...
Aim: We aimed to evaluate trifecta outcomes after Retzius-sparing robot-assisted radical prostatecto...
We investigated the surgical outcome for robotic-assisted laparoscopic radical prostatectomy (RALP) ...
Background: Robot-assisted laparoscopic radical prostatectomy (RALP) is an evolving minimally invasi...
Background To report the perioperative, functional and oncological outcomes of salvage robot-assiste...
Background To report the perioperative, functional and oncological outcomes of salvage robot-assiste...
INTRODUCTION & OBJECTIVES: There is a significant cohort of patients who experience recurrent prosta...
INTRODUCTION & OBJECTIVES: There is a significant cohort of patients who experience recurrent pr...
PURPOSE: Cancer control outcomes following robot-assisted radical prostatectomy (RARP) for prostate ...
Objective: We report our initial experience with 62 patients undergoing robotic-assisted laparoscopi...
OBJECTIVE • To evaluate early trifecta outcomes after robotic-assisted radical prostatectomy (RARP) ...
To analyze the learning curve for cancer control from an initial 250 cases (Group I) and subsequent ...
OBJECTIVE: To evaluate the trifecta outcome and its preoperative predictors in a series of consecuti...
Introduction: In this retrospective study, we report outcomes of robot-assisted laparoscopic radical...
Historically, the ideal outcome of radical prostatectomy (RP) has been measured by achievement of th...
Historically, the ideal outcome of radical prostatectomy (RP) has been measured by achievement of th...
Aim: We aimed to evaluate trifecta outcomes after Retzius-sparing robot-assisted radical prostatecto...
We investigated the surgical outcome for robotic-assisted laparoscopic radical prostatectomy (RALP) ...
Background: Robot-assisted laparoscopic radical prostatectomy (RALP) is an evolving minimally invasi...
Background To report the perioperative, functional and oncological outcomes of salvage robot-assiste...
Background To report the perioperative, functional and oncological outcomes of salvage robot-assiste...
INTRODUCTION & OBJECTIVES: There is a significant cohort of patients who experience recurrent prosta...
INTRODUCTION & OBJECTIVES: There is a significant cohort of patients who experience recurrent pr...
PURPOSE: Cancer control outcomes following robot-assisted radical prostatectomy (RARP) for prostate ...
Objective: We report our initial experience with 62 patients undergoing robotic-assisted laparoscopi...
OBJECTIVE • To evaluate early trifecta outcomes after robotic-assisted radical prostatectomy (RARP) ...
To analyze the learning curve for cancer control from an initial 250 cases (Group I) and subsequent ...